LivaloV

DRUG2 trials

Sponsors

JW Pharmaceutical

Conditions

DyslipidemiaHealthyHypertension

Phase 1

To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers

CompletedNCT05351840

JW PharmaceuticalHealthy

Start: 2020-11-02End: 2021-01-15Updated: 2022-08-12

Phase 3

To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension

CompletedNCT05331014

JW PharmaceuticalDyslipidemia, Hypertension

Start: 2021-11-15End: 2022-11-08Updated: 2024-03-15